Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aspirin for Preeclampsia Prevention in Oocyte Donation Recipients (PROVAS)
NCT02174328Phase 3Terminated
- Sponsor
- Health Research Institute Hospital La Fe
- Start
- May 2014
- Primary completion
- Apr 2018
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of aspirin in preeclampsia, sponsored by Health Research Institute Hospital La Fe. Started May 2014; status: terminated.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT02174328.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02174328.